Veracyte (VCYT) 2025 Earnings Preview: Investor Guide
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
Explore which index funds have the lowest fees to improve retirement planning. Learn how expense ratios impact long-term growth and how to pick cost-efficient options.
27,827 articlesAs Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
Duolingo is quietly reshaping its AI approach to learning. This piece explains why the duolingo most interesting play...
As AI workloads surge, investors wonder if Applied Digital could be an undervalued play. This guide breaks down how t...
Bitcoin tumbled in a rapid flash dump as tariff headlines roiled markets, sparking risk-off selling and erasing sever...
Bitcoin faces a sharp deleveraging as more than $370 million in liquidations hit long bets, while corporate buyers mo...
Bitcoin resumes strength amid a broader risk-off backdrop for gold. The bitcoin resurgence faces a critical test near...
Bitcoin traded under $68,000 as a wave of liquidations hit the market, pushing the total to just over $1 billion. Mor...
Bitcoin has staged a rebound but faces a pivotal test near mid-$60,000s. This bitcoin price analysis: ready framework...
The Supreme Court’s Feb. 20 decision voids the tariff program, setting up a possible $175 billion refunds wave that c...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...